United States: Zubillaga V. Allstate Indemnity Company

In Zubillaga v. Allstate Indemnity Company, 12 Cal.App.5th1017, the Court of Appeal of California, Fourth Appellate District reversed the trial court's grant of summary judgment to Allstate, finding there were triable issues of material fact regarding whether Allstate's coverage determination was made without a good faith investigation and without a reasonable basis for a genuine dispute.

Plaintiff had an automobile policy with Allstate that included UIM coverage with a $50,000 per person limit, to be reduced by any amounts paid by the owner or operator of the underinsured car, and provided for voluntary binding arbitration. Plaintiff was in a serious accident, for which the police determined the other driver was at fault. According to the police report, Plaintiff complained of pain to her face and arm, and did not report any back injury or back pain. Instead of following up with her own doctor, she saw a chiropractor – 39 times over the following four months. Plaintiff also saw an osteopath who determined a MRI of Plaintiff's cervical spine indicated multiple disc protrusions, which would likely require future medical treatment. Plaintiff's attorney made a demand on Allstate for $35,000 (the policy limit after deducting the other driver's $15,000 settlement), based on her current medical bills of $17,645.44 and lower back pain for the remainder of her life expectancy. Allstate offered to settle the matter for $9,367, which it calculated by taking its determination of the reasonable and customary amount for Plaintiff's medical bills ($14,367), adding $10,000 in general damages, then subtracting the $15,000 settlement from the other driver. The next day, Plaintiff served a formal offer to compromise (per Section 998) for $35,000; Plaintiff did not otherwise respond to Allstate's offer for more than four months, at which point Plaintiff's counsel formally rejected the offer and again demanded $35,000, providing two evaluations by a board certified orthopedic surgeon. These evaluations increased Plaintiff's medical expenses by $1,200, and did not reference any need for epidural steroid injections. Allstate increased its evaluation of the claim to $25,000 due to Plaintiff's continuing complaints of back pain; Allstate increased its settlement offer to $10,000. Plaintiff's counsel rejected this offer, renewed her $35,000 demand, demanded arbitration, and requested Allstate assign counsel to handle the claim. Allstate assigned counsel, and served written discovery. Plaintiff's responses to the written discovery reference a consultation with a board certified pain management specialist and anesthesiologist, and both he and the osteopath opined she will require epidural injections, anti-inflammatory and pain medication, and physical therapy. Plaintiff's counsel sent Allstate Plaintiff's medical records from the pain management specialist, who diagnosed Plaintiff with lumbar disc herniation and opined the information provided is consistent with the car accident as the cause of her pain. The specialist also opined Plaintiff would need lumbar epidural steroid injections, which would range from $15,000-20,000 for one to $45,000-60,000 for three. Allstate increased its valuation to $27,084, offering Plaintiff $12,084. Allstate also retained a board certified orthopedic surgeon to perform a defense medical examination, review the medical records, and determine if the injections were appropriate. The surgeon provided three reports, which disagree as to the necessity of the injections. 

Plaintiff's counsel requested arbitration set for at least three months out, to accommodate Plaintiff being scheduled to receive an injection in the following weeks. Allstate responded, and requested any new records and bills for review and re-evaluation prior to the arbitration date. Allstate received additional medical records, supporting an additional claim of $6,850 in medical expenses for a steroid injection. With this new expense, Plaintiff's medical bills totaled $26,455.44; Allstate offered $14,500. Plaintiff's counsel provided a report from the doctor who administered the steroid injection, opining Plaintiff may need an additional three injections (costing $12,000 each) in conjunction with medications and physical therapy, each of which would likely cost $6,000 per year. Allstate did not have its expert review this report, but instead increased the valuation to $30,584, and offered $15,584.

During arbitration, Plaintiff produced an additional report from her doctor who had provided the injections, which had not been provided to Allstate before, that Plaintiff argued proved future injections were necessary and appropriate. The arbitrator found for Plaintiff, awarding her $35,000 ($21,205 in economic damages, and $13,795 in non-economic damages). Allstate paid the arbitration award. 

Plaintiff sued Allstate for breach of contract and bad faith, claiming Allstate "did not fairly investigate her claim and should have paid her the UIM policy limits sooner." The trial court granted Allstate's motion for summary judgment as to Plaintiff's bad faith cause of action on the genuine dispute doctrine, finding "Defendant Allstate was permitted to rely on its expert's opinion, who had a history of all of Plaintiff's treating doctors [ . . . ] to determine that her treatment was excessive and she did not need the expensive steroid injections." 

The Court reviewed California law regarding the implied covenant of good faith and fair dealing, including that an insurer cannot ignore available evidence supporting a claim in favor of facts justifying denial. However, an insurer is not liable for a failure to pay or delay in paying policy benefits where there is a genuine dispute as to coverage, which applies to both legal and factual disputes. An insurer is only entitled to a grant of summary judgment on this basis "where the summary judgment record demonstrates the absence of triable issues [citation] as to whether the disputed position upon which the insurer denied the claim was reached reasonably and in good faith. [Citation.]." Determining whether a dispute is legitimate is an objective standard, and must be evaluated as of the time the decisions were made, and not in light of any subsequent events showing error. Additionally, there may be a basis for application of the genuine dispute doctrine where the insurer relies on the advice of experts – although reliance on expert advice does "not automatically insulate an insurer from a bad faith claim." 

The Court noted the problem with Allstate's reliance on its expert: the expert rendered his opinions in October and November 2012, yet Allstate continued to rely on the opinions through arbitration in September 2013, without consulting him again or conducting further investigation, particularly as to the injections Plaintiff was receiving. 

Because it never asked Legome [Allstate's expert] to review Soni's [the doctor administering the injections] epidural treatments and recommendations, Allstate's continued reliance upon Legome's opinions as the basis for disputing the medical necessity or reasonable value of those treatments and recommendations may have been unreasonable. And, leaving aside Legome's reports and opinions, Allstate has not directed us to any other medical reports or opinions that could reasonably support its ongoing denial of plaintiff's claim.

Of course, Allstate was not obliged to accept Soni's treatments and recommendations "without scrutiny or investigation." [Citation.] To the extent it had good faith doubts, Allstate had the right to further investigate the basis for plaintiff's claim by having Legome reexamine his 2012 opinions, having another physician review all of plaintiff's medical records and offer opinions, or, if necessary, having plaintiff further examined by Legome or another defense doctor.

What Allstate could not do, consistent with the implied covenant of good faith and fair dealing, was to ignore Soni's treatments and recommendations, without adequately investigating them. [Citation.] To be clear, we are not saying Allstate breached the implied covenant. We are saying a reasonable jury could conclude it did so. Allstate's assertion it reasonably continued to rely on Legome's opinions, or that it had inadequate time to have him reexamine those opinions or conduct further investigation, merely inform our conclusion plaintiff has demonstrated triable issues of material fact that cannot be resolved by summary judgment.

For these same reasons, the court erred by granting summary judgment based upon the genuine dispute doctrine. Again, the genuine dispute rule does not relieve an insurer from its obligation to thoroughly and fairly investigate the insured's claim, and a genuine dispute exists only where the insurer's position is maintained in good faith and on reasonable grounds. Once more, an insurer is not entitled to judgment as a matter of law where, viewing the facts in the light most favorable to the plaintiff, a jury could conclude that the insurer acted unreasonably. [Citation.]

Considering the objective facts known to Allstate at the time its final decision to deny plaintiff's $35,000 demand was made, and viewing the evidence in the light most favorable to plaintiff as required, we are convinced "'a jury could conclude that the insurer acted unreasonably.'" [Citation.] Specifically, there is sufficient evidence for a jury to find Allstate's continued insistence she did not need expensive epidural injections was, "'"prompted not by an honest mistake, bad judgment or negligence but rather by a conscious and deliberate act, which unfairly frustrates the agreed common purposes and disappoints the reasonable expectations of the other party thereby depriving that party of the benefits of the agreement."'" [Citation.]

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.